analysis by تهران بورس about Stock دارو: Buy recommendation (10/20/2025)

This symbol was negative. Today, #DOLLAR below 670, special review. There are drugs with a foundation that are badly controlled and did not give growth rent to the share. It has two capacity increase plans, one of which will end this month, and the other one will end next month. I expect that with the formation of plans, we will have a different second half of the year with Deller. Deller is one of the few risks in the market that can be trusted even in bad market conditions and does not fall much. See #Caspian, #Daroo, #Desina and #Dabur! Deler should grow like these. Because it is profitable and fundamental.